---------------------------------
QMB APPROVAL
---------------------------------
QMB Number: 3235-0145
Expires: October 31, 1994
Estimated average burden
hours per form............14.90
---------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
Hemasure Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.0001 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
423504109
---------------------------------
(CUSIP Number)
Edwin H. Morgens, 10 East 50th Street, New York, NY 10022, (212) 705-0500
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
October 16, 1996
---------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|.
Check the following box if a fee is being paid with the statement [X]. (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 17 Pages
Exhibit Index Appears on Page 17
<PAGE>
SCHEDULE 13D
CUSIP No. 423504109 Page 2 of 17 Pages
_________________________________________________________________
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Phoenix Partners
13-6272912
_________________________________________________________________
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [x]
_________________________________________________________________
3) SEC USE ONLY
_________________________________________________________________
4) SOURCE OF FUNDS*
WC
_________________________________________________________________
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
_________________________________________________________________
6) CITIZENSHIP OR PLACE OF ORGANIZATION
New York State
_________________________________________________________________
NUMBER 7) SOLE VOTING POWER
OF 211,900 - See Response to Item 5
SHARES _______________________________________________
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
EACH _______________________________________________
REPORTING 9) SOLE DISPOSITIVE POWER
PERSON 211,900 - See Response to Item 5
WITH _______________________________________________
10) SHARED DISPOSITIVE POWER
0
_________________________________________________________________
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
211,900
_________________________________________________________________
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
_________________________________________________________________
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.6%
_________________________________________________________________
14) TYPE OF REPORTING PERSON*
PN
_________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 423504109 Page 3 of 17 Pages
_________________________________________________________________
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Betje Partners
13-3118883
_________________________________________________________________
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [x]
_________________________________________________________________
3) SEC USE ONLY
_________________________________________________________________
4) SOURCE OF FUNDS*
WC
_________________________________________________________________
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
_________________________________________________________________
6) CITIZENSHIP OR PLACE OF ORGANIZATION
New York State
_________________________________________________________________
NUMBER 7) SOLE VOTING POWER
OF 73,500 - See Response to Item 5
SHARES _______________________________________________
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
EACH _______________________________________________
REPORTING 9) SOLE DISPOSITIVE POWER
PERSON 73,500 - See Response to Item 5
WITH _______________________________________________
10) SHARED DISPOSITIVE POWER
0
_________________________________________________________________
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
73,500
_________________________________________________________________
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
_________________________________________________________________
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.9%
_________________________________________________________________
14) TYPE OF REPORTING PERSON*
PN
_________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 423504109 Page 4 of 17 Pages
_________________________________________________________________
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Morgens Waterfall Vintiadis Investments N.V.
None
_________________________________________________________________
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [x]
_________________________________________________________________
3) SEC USE ONLY
_________________________________________________________________
4) SOURCE OF FUNDS*
WC
_________________________________________________________________
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
_________________________________________________________________
6) CITIZENSHIP OR PLACE OF ORGANIZATION
Netherlands Antilles
_________________________________________________________________
NUMBER 7) SOLE VOTING POWER
OF 131,100 - See Response to Item 5
SHARES _______________________________________________
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
EACH _______________________________________________
REPORTING 9) SOLE DISPOSITIVE POWER
PERSON 131,100 - See Response to Item 5
WITH _______________________________________________
10) SHARED DISPOSITIVE POWER
0
_________________________________________________________________
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
131,100
_________________________________________________________________
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
_________________________________________________________________
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
1.6%
_________________________________________________________________
14) TYPE OF REPORTING PERSON*
CO
_________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 423504109 Page 5 of 17 Pages
_________________________________________________________________
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MWV Employee Retirement Plan Group Trust
13-3845507
_________________________________________________________________
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [x]
_________________________________________________________________
3) SEC USE ONLY
_________________________________________________________________
4) SOURCE OF FUNDS*
WC
_________________________________________________________________
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
_________________________________________________________________
6) CITIZENSHIP OR PLACE OF ORGANIZATION
New York State
_________________________________________________________________
NUMBER 7) SOLE VOTING POWER
OF 21,000 - See Response to Item 5
SHARES _______________________________________________
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
EACH _______________________________________________
REPORTING 9) SOLE DISPOSITIVE POWER
PERSON 21,000 - See Response to Item 5
WITH _______________________________________________
10) SHARED DISPOSITIVE POWER
0
_________________________________________________________________
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
21,000
_________________________________________________________________
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
_________________________________________________________________
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.3%
_________________________________________________________________
14) TYPE OF REPORTING PERSON*
EP
_________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 423504109 Page 6 of 17 Pages
_________________________________________________________________
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Phaeton International N.V.
None
_________________________________________________________________
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [x]
_________________________________________________________________
3) SEC USE ONLY
_________________________________________________________________
4) SOURCE OF FUNDS*
AF
_________________________________________________________________
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
_________________________________________________________________
6) CITIZENSHIP OR PLACE OF ORGANIZATION
Netherlands Antilles
_________________________________________________________________
NUMBER 7) SOLE VOTING POWER
OF 0 - See Response to Item 5
SHARES _______________________________________________
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
EACH _______________________________________________
REPORTING 9) SOLE DISPOSITIVE POWER
PERSON 0 - See Response to Item 5
WITH _______________________________________________
10) SHARED DISPOSITIVE POWER
0
_________________________________________________________________
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
131,100
_________________________________________________________________
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
_________________________________________________________________
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
1.6%
_________________________________________________________________
14) TYPE OF REPORTING PERSON*
CO
_________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 423504109 Page 7 of 17 Pages
_________________________________________________________________
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Morgens, Waterfall, Vintiadis & Company, Inc.
13-2674766
_________________________________________________________________
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [x]
_________________________________________________________________
3) SEC USE ONLY
_________________________________________________________________
4) SOURCE OF FUNDS*
AF
_________________________________________________________________
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
_________________________________________________________________
6) CITIZENSHIP OR PLACE OF ORGANIZATION
New York State
_________________________________________________________________
NUMBER 7) SOLE VOTING POWER
OF 0 - See Response to Item 5
SHARES _______________________________________________
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
EACH _______________________________________________
REPORTING 9) SOLE DISPOSITIVE POWER
PERSON 0 - See Response to Item 5
WITH _______________________________________________
10) SHARED DISPOSITIVE POWER
0
_________________________________________________________________
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
204,600
_________________________________________________________________
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
_________________________________________________________________
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.5%
_________________________________________________________________
14) TYPE OF REPORTING PERSON*
CO
_________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 423504109 Page 8 of 17 Pages
_________________________________________________________________
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Edwin H. Morgens
###-##-####
_________________________________________________________________
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [x]
_________________________________________________________________
3) SEC USE ONLY
_________________________________________________________________
4) SOURCE OF FUNDS*
AF
_________________________________________________________________
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
_________________________________________________________________
6) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
_________________________________________________________________
NUMBER 7) SOLE VOTING POWER
OF 0 - See Response to Item 5
SHARES _______________________________________________
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
EACH _______________________________________________
REPORTING 9) SOLE DISPOSITIVE POWER
PERSON 0 - See Response to Item 5
WITH _______________________________________________
10) SHARED DISPOSITIVE POWER
0
_________________________________________________________________
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
437,500
_________________________________________________________________
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
_________________________________________________________________
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.4%
_________________________________________________________________
14) TYPE OF REPORTING PERSON*
IN
_________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 423504109 Page 9 of 17 Pages
_________________________________________________________________
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Bruce Waterfall
###-##-####
_________________________________________________________________
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [x]
_________________________________________________________________
3) SEC USE ONLY
_________________________________________________________________
4) SOURCE OF FUNDS*
AF
_________________________________________________________________
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
_________________________________________________________________
6) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
_________________________________________________________________
NUMBER 7) SOLE VOTING POWER
OF 0 - See Response to Item 5
SHARES _______________________________________________
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
EACH _______________________________________________
REPORTING 9) SOLE DISPOSITIVE POWER
PERSON 0 - See Response to Item 5
WITH _______________________________________________
10) SHARED DISPOSITIVE POWER
0
_________________________________________________________________
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
416,500
_________________________________________________________________
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
_________________________________________________________________
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.2%
_________________________________________________________________
14) TYPE OF REPORTING PERSON*
IN
_________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Hemasure Inc. Page 10 of 17 Pages
Schedule 13D October 23, 1996
Item 1. Security and Issuer.
- ------- --------------------
This statement on Schedule 13D ("Statement") relates to the common
stock, par value $.01 per share ("Common Stock"), of Hemasure Inc. (the
"Issuer"). The principal executive offices of the Issuer are located at 140
Locke Drive, Marlborough, Massachusetts 01752.
Item 2. Identity and Background.
This Statement is filed jointly by (a) Phoenix Partners ("Phoenix"),
(b) Betje Partners ("Betje"), (c) Morgens Waterfall Vintiadis Investments N.V.
("MWV"), (d) MWV Employee Retirement Plan Group Trust ("MWV Plan"), (e) Phaeton
International N.V. ("Phaeton"), (f) Morgens, Waterfall, Vintiadis & Company,
Inc. ("Morgens Waterfall"), (g) Edwin H. Morgens ("Morgens") and (h) Bruce
Waterfall ("Waterfall" and together with the persons listed in paragraphs (a)
through (h), the "Reporting Persons").
MWV is a subsidiary of Phaeton. Phaeton is a controlling person of MWV
by virtue of its ownership of 100% of the outstanding shares of MWV. Phaeton and
MWV are Netherlands Antilles limited liability companies having their principal
offices at 6 John B. Gorsiraweg, Willemstad, Curacao, Netherlands Antilles. The
principal business of MWV is to invest in securities of United States issuers.
Phaeton is a holding company which invests in MWV and companies with similar
objectives.
The sole Managing Director of Phaeton and MWV is Offshore Management
Company N.V. ("Offshore"), a Netherlands Antilles limited liability company
having its principal office at 6 John B. Gorsiraweg, Willemstad, Curacao,
Netherlands Antilles. The principal business of Offshore is to act as Managing
Director of corporations domiciled in the Netherlands Antilles, and in that
capacity to provide local management, administrative, clerical and accounting
services similar to those which it provides to Phaeton and MWV. Phaeton and MWV
do not have any officers other than Offshore.
Phaeton and MWV have the following Board of Directors:
Name Address
---- -------
Halvor Astrup Fearnley Group A/S
35-38 Portman Square
London W1HOEU, England
<PAGE>
Hemasure Inc. Page 11 of 17 Pages
Schedule 13D October 23, 1996
Dr. M. Colyer Crum Harvard Business School
Cambridge, Massachusetts
Bassam Aburdene Capital Trust Ltd.
49 Mount Street
London WIY5RE, England
Fred Arthur Rank Packard Center 45
45 London Wall
London EC2, England
Mr. Astrup, a citizen of Norway, is Vice Chairman of Fearnley Group
and Chairman of Fearnley Finance Ltd., companies principally engaged in project
development in the international shipping industry.
Dr. Crum, a U.S. citizen, is a professor at the Harvard Business
School, where he holds the James R. Williston Chair of Investment Management.
Mr. Aburdene, a U.S. citizen, is a Managing Partner of Capital Trust
Limited, a London-based financial services company which is jointly owned by
United States and Middle Eastern institutions and investors.
Mr. Packard, a British citizen, is a partner of Banco de Investimentos
Garantia, a leading Brazilian investment bank.
Phoenix and Betje are New York limited partnerships having their
principal address at 10 East 50th Street, New York, New York 10022. The
principal business of Phoenix and Betje is to invest in securities of United
States issuers. Morgens and Waterfall are the managing members of MW Management
LLC, which is the general partner of Phoenix. All of the information concerning
Morgens and Waterfall is set forth below. Mr. Zanvyl Krieger is the general
partner of Betje. The business address of Mr. Krieger is c/o Weinberg and Green,
100 South Charles Street, Baltimore, Maryland 21201. Mr. Krieger's principal
occupation is a private investor.
MWV Plan is a trust established in 1994 for the benefit of the
employees of Morgens Waterfall. The trustees of the MWV Plan are David Ericson,
Dan Levinson, Morgens, John Raphael and Stephan Yost, all of whom are employees
of Morgens Waterfall. MWV Plan's principal address is 10 East 50th Street, New
York, New York 10022. All of the relevant information concerning Morgens
Waterfall and Morgens is set forth below.
Morgens Waterfall is a New York corporation having its principal
address at 10 East 50th Street, New York, New York 10022.
<PAGE>
Hemasure Inc. Page 12 of 17 Pages
Schedule 13D October 23, 1996
The business of Morgens Waterfall is rendering of financial services and as such
it provides discretionary investment advisory services pursuant to contracts
with MWV and Betje. Under the rules promulgated by the Securities and Exchange
Commission, Morgens Waterfall and its principals may be considered "beneficial
owners" of securities acquired by MWV and Betje as a result of its advisory
relationship to MWV and Betje.
Morgens is the Chairman of the Board of Directors and the Secretary of
Morgens Waterfall. Waterfall is the President and Assistant Secretary of Morgens
Waterfall and is also a Director. The primary occupations of Morgens and
Waterfall are to act as the principals in the business of Morgens Waterfall. The
business address of Morgens and Waterfall, each of whom is a United States
citizen, is at the office of Morgens Waterfall at 10 East 50th Street, New York,
New York 10022. Morgens Waterfall has no other officers and directors.
During the past five years, none of the persons described in this Item
2 have been convicted in a criminal proceeding. None of such persons is, and
during the past five years none has been, subject to a judgment, decree or final
order enjoining future violations of, or prohibiting or mandating activities
subject to, federal or state securities laws, or finding any violations with
respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration.
- ------- --------------------------------------------------
The Common Stock held by the Reporting Persons was purchased in the
over-the-counter market through brokerage transactions. The source of the
payments by Phoenix, Betje, MWV and MWV Plan was working capital, and no part of
the purchase price was represented by funds or other consideration specially
borrowed or otherwise specifically obtained for the purpose of acquiring,
holding, trading or voting the securities.
Item 4. Purpose of Transaction.
- ------- -----------------------
The Common Stock was acquired by Phoenix, Betje, MWV and MWV Plan in
the over-the-counter market through brokerage transactions in the ordinary
course of business, solely as an investment. The Reporting Persons have no
present plans or proposals that relate to or would result in any of the actions
enumerated in Item 4 of Schedule 13D, although they reserve the right to buy
additional securities of the Issuer or sell securities of the Issuer from time
to time.
<PAGE>
Hemasure Inc. Page 13 of 17 Pages
Schedule 13D October 23, 1996
Item 5. Interest in Securities of the Issuer.
(a) and (b) The following is the amount of Common Stock that is
is beneficially owned by each Reporting Person:
Aggregate Percentage
Name # of Shares of Class
---- ----------- --------
Phoenix 211,900 2.6
Betje 73,500 0.9
MWV 131,100 1.6
MWV Plan 21,000 0.3
------ ----
Total 437,500 5.4
Phaeton does not directly own any of the Common Stock. Phaeton may be
deemed to indirectly beneficially own 131,100 shares of Common Stock by virtue
of its 100% ownership of MWV.
Morgens Waterfall does not directly own any of the Common Stock.
Morgens Waterfall may be deemed to indirectly beneficially own 204,600 shares of
Common Stock by virtue of contracts with MWV (131,100 shares) and Betje (73,500
shares) pursuant to which Morgens Waterfall provides discretionary investment
advisory services.
Morgens does not directly own any of the Common Stock. Morgens may be
deemed to indirectly beneficially own 437,500 shares of Common Stock by virtue
of his positions as Chairman of the Board of Directors and Secretary of Morgens
Waterfall (204,600 shares); as a managing member of MW Management LLC, which is
the general partner of Phoenix (211,900 shares); and as trustee of MWV Plan
(21,000 shares).
Waterfall does not directly own any of the Common Stock. Waterfall may
be deemed to indirectly beneficially own 416,500 shares of Common Stock by
virtue of his positions as President, Assistant Secretary and a Director of
Morgens Waterfall (204,600 shares) and as a managing member of MW Management
LLC, which is the general partner of Phoenix (211,900 shares).
Each Reporting Person hereby disclaims that it has any beneficial
interest in the securities owned, directly or indirectly, by any other entity.
The following is a list of all transactions involving the Common Stock
during the past 60 days by any of the Reporting Persons:
<PAGE>
Hemasure Inc. Page 14 of 17 Pages
Schedule 13D October 23, 1996
No. of Shares Price/
Name Date Sold/Purchased Share
- ---- ---- -------------- -----
Phoenix 9/18/96 12,000 sold $10.875
10/04/96 22,300 purchased 9.25
10/15/96 47,900 purchased 8.50
10/16/96 30,700 purchased 8.50
10/17/96 2,500 purchased 8.50
Betje 9/18/96 900 sold $10.875
10/04/96 7,600 purchased 9.25
10/15/96 16,100 purchased 8.50
10/16/96 10,500 purchased 8.50
10/17/96 900 purchased 8.50
MWV 9/18/96 2,000 sold $10.875
10/04/96 13,600 purchased 9.25
10/15/96 29,000 purchased 8.50
10/16/96 18,800 purchased 8.50
10/16/9 1,600 purchased 8.50
MWV Plan 10/15/96 7,000 purchased $ 8.50
(d) Except as set forth above, no other person is known to have the
right to receive or the power to direct the receipt of dividends from, or the
proceeds from the sale of, the Common Stock.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with
- ------- Respect to the Securities of the Issuer.
Except to the extent described in Items 2 and 5, none of the persons
identified in Item 2 is a party to any contract, arrangement, understanding or
relationship with respect to any securities of the Issuer.
<PAGE>
Hemasure Inc. Page 15 of 17 Pages
Schedule 13D October 23, 1996
Item 7. Material to be Filed as Exhibits.
EXHIBIT A Power of Attorney, dated December 15, 1993 granted to
Messrs. Morgens and Waterfall by the following parties: Mr.
Bruce Waterfall; Phoenix Partners; Morgens Waterfall Income
Partners; Betje Partners; Phaeton International N.V.; Morgens,
Waterfall, Vintiadis Investments N.V.; The Common Fund for
Non-Profit Organizations; Morgens Waterfall Vintiadis & Company,
Inc.; Restart Partners, L.P.; Restart Partners II, L.P.; Restart
Partners III, L.P.; Restart Partners IV, L.P.; Morgens Waterfall,
Vintiadis & Co., Inc. Employees' Profit Sharing Plan; and Mr.
Edwin Morgens, for the specific purpose of executing on their
behalf any Schedule 13Ds and amendments thereto for filing with
the Securities and Exchange Commission pursuant to the
requirements of Rule 13d-1(f) (incorporated by reference to
Exhibit A of Amendment No. 2 to Schedule 13D filed on December
22, 1993 by Phoenix Partners; Betje Partners; Phaeton
International N.V.; Morgens, Waterfall, Vintiadis Investments
N.V.; Morgens Waterfall Vintiadis & Company, Inc.; Edwin H.
Morgens; and Bruce Waterfall with respect to the common stock,
par value $.01 per share, of Sudbury, Inc.).
EXHIBIT B Power of Attorney, dated as of June 20, 1994 granted to
Messrs. Morgens and Waterfall by Morgens Waterfall Overseas
Partners, for the specific purpose of executing on its behalf any
Schedule 13Ds and amendments thereto for filing with the
Securities and Exchange Commission pursuant to the requirements
of Rule 13d-1(f) (incorporated by reference to Exhibit B of
Schedule 13D filed on June 23, 1994 by Morgens Waterfall Overseas
Partners; Morgens Waterfall Income Partners; Morgens Waterfall,
Vintiadis & Co., Inc.; Restart Partners, L.P.; Restart Partners
II, L.P.; Restart Partners III, L.P.; Restart Partners IV, L.P.;
Morgens Waterfall, Vintiadis & Co., Inc. Employees' Profit
Sharing Plan; The Common Fund for Non-Profit Organizations; Edwin
H. Morgens; and Bruce Waterfall with respect to the common stock,
par value $1.00 per share, of Best Products Co., Inc.).
<PAGE>
Hemasure Inc. Page 16 of 17 Pages
Schedule 13D October 23, 1996
SIGNATURES
After reasonable inquiry and to the best knowledge and belief
of each of the Reporting Persons, each such person or entity certifies that the
information set forth in this statement is true, complete and correct and agrees
that this statement is filed on behalf of each of them.
The Reporting Persons listed herein
Dated: October 23, 1996 By: /s/ Bruce Waterfall
--------------------------------
Bruce Waterfall, as attorney-in-
fact for each of the Reporting
Persons
<PAGE>
Hemasure Inc. Page 17 of 17 Pages
Schedule 13D October 23, 1996
EXHIBIT INDEX
Page No.
---------
Exhibit A Power of Attorney Incorporated by
Reference
Exhibit B Power of Attorney Incorporated by
Reference
<PAGE>
